Replimune (REPL) Capital Expenditures (2017 - 2026)
Replimune (REPL) recorded Capital Expenditures of $6,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 99.8% from $2.74 million a year earlier but up 20.0% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Capital Expenditures (2017 - 2026) Analysis & Trends
On a TTM basis, Replimune's Capital Expenditures came in at $1.49 million as of Jun 30, 2026, down 80.8% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $4.22 million, down 36.8% from FY2025.
- Annual Capital Expenditures has a five-year compound annual growth rate of 12.0% (FY2021 to FY2026).
- Across earlier fiscal years, Capital Expenditures came in at $6.69 million in FY2025 (+18.1%), $5.66 million in FY2024 (+149.4%), $2.27 million in FY2023 (-2.8%) and $2.34 million in FY2022 (-2.3%).
- Quarterly Capital Expenditures has ranged from $5,000 in fiscal Q4 2026 to $2.74 million in fiscal Q1 2026 over the past five years.
- On a year-over-year basis, Capital Expenditures has declined for four consecutive quarters, with an average decline of 34.3% over the last eight quarters.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 593.2% in fiscal Q4 2024, against a decline of 99.8% in fiscal Q1 2027 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $5,000 (Q4 2026), $135,000 (Q3 2026) and $1.34 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Replimune | 1.05 Bn | 1.05 Bn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 1.72 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 449,000.00 |
| Mar 31, 2023 | 251,000.00 |
| Dec 31, 2022 | 555,000.00 |
| Sep 30, 2022 | 396,000.00 |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 465,000.00 |
| Sep 30, 2021 | 428,000.00 |
API Access
Replimune Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();